Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.

Mina, Michael J; Peto, Tim E; García-Fiñana, Marta; Semple, Malcolm G; Buchan, Iain E

Mina, Michael J; Peto, Tim E; García-Fiñana, Marta; Semple, Malcolm G; Buchan, Iain E.

Mina MJ; Center for Communicable Disease Dynamics, Department of Epidemiology and Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health and Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Peto TE; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
García-Fiñana M; Institute of Population Health, University of Liverpool, Liverpool L36 3GF, UK.
Semple MG; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Buchan IE; Institute of Population Health, University of Liverpool, Liverpool L36 3GF, UK. Electronic address: buchan@liverpool.ac.uk.

Lancet ; 397(10283): 1425-1427, 2021 04 17.

Article in English | MEDLINE | ID: covidwho-1087332

Subject(s)

COVID-19 Serological Testing; COVID-19/diagnosis; Public Health Administration; COVID-19 Nucleic Acid Testing; Humans; SARS-CoV-2; Sensitivity and Specificity; United Kingdom

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health Administration / COVID-19 Serological Testing / COVID-19 Type of study: Diagnostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)00425-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google